Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-16-118533
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-09 17:35:34
Reporting Period:
2016-05-05
Filing Date:
2016-05-09
Accepted Time:
2016-05-09 17:35:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011835 Medivation Inc. MDVN Pharmaceutical Preparations (2834) 133863260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604351 Rick Bierly C/o Medivation, Inc.
525 Market St., 36Th Floor
San Francisco CA 94105
Cfo (Former) No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-05-05 4,025 $59.20 35,059 No 4 S Direct
Common Stock Disposition 2016-05-06 5,915 $60.08 29,144 No 4 S Direct
Common Stock Disposition 2016-05-06 400 $60.66 28,744 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
  2. Shares sold pursuant to a 10b5-1 trading plan.
  3. The shares were sold at prices between $59.56 and $60.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares were sold at prices between $60.58 and $60.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.